Mycophenolate sodium (enteric coated)

DRUG4 trials

Sponsors

Novartis, Novartis Pharmaceuticals

Conditions

Renal Transplant

Phase 3

Study of Enteric-coated Mycophenolate Sodium Versus Mycophenolate Mofetil in Adult de Novo Renal Transplant Patients

CompletedNCT00149903

Novartis PharmaceuticalsRenal Transplant

Start: 2005-01-31Target: 300Updated: 2016-11-18

Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A0107

CompletedNCT00149916

Novartis PharmaceuticalsRenal Transplant

Start: 2000-04-30Updated: 2011-11-02

Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A302

CompletedNCT00149864

NovartisRenal Transplant

Start: 2000-02-29End: 2003-12-31Updated: 2011-02-02

Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A301

CompletedNCT00149929

NovartisRenal Transplant

Start: 1999-12-31End: 2003-04-30Updated: 2011-02-02